Article
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
21 Sept 2014
Abstract excerpt
Chimeric antigen receptors (CARs) are recombinant receptors that combine the specificity of an antigen-specific antibody with the T-cell's activating functions. Initial clinical trials of genetically engineered CAR T cells have significantly raised the profile of T cell therapy, and great efforts have been made to improve this approach. In this review, we provide a structural overview of the development of CAR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
